Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $3.32 is 21.61% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 3.42||$ 8.8916|
|Low:||$ 3.27||$ 2.73|
Company Description (as filed with the SEC)
CASI Pharmaceuticals, Inc. ("CASI", the "Company") (Nasdaq: CASI) is a U.S. based biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients. We intend to execute our plan to become a leading pharmaceutical company with a substantial market share in China. We are headquartered in Rockville, Maryland with established China operations that are growing as we continue to further in-license or acquire products for our pipeline. Our product pipeline features (1) EVOMELA®, MARQIBO®, and ZEVALIN®, all U.S. Food and Drug Administration ("FDA") approved drugs in-licensed from Spectrum Pharmaceuticals, Inc. ... More ...
Nasdaq Official Price
Mar. 20, 2019